Targeted Antibody Therapy Offers Long-Lasting Neuropathic Pain Relief
_6e98296023b34dfabc133638c1ef5d32-620x480.jpg)
Humanized antibodies targeting the Nav1.7 sodium ion channel provide long-lasting relief from neuropathic pain in preclinical rat models while preserving normal pain sensation and motor function, according to a study published on June 21, 2026, in Volume 18 of Pharmaceutics. Researchers led by Associate Professor Daisuke Uta of the University of Toyama and Dr. Sosuke … Read more